The Vascular Endothelial Growth Factor A–Vascular Endothelial Growth Factor Receptor 2 Axis Drives Malignant Potential in Oral Squamous Cell Carcinoma by Promoting Stemness and Cell Proliferation
The American Journal of Pathology · 2026
DOI: 10.1016/j.ajpath.2026.07.011 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Pathology, 2026. Verfasst von Li-Jie Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Pathology, University of Osaka Graduate School of Dentistry, Suita, Japan; Ph.D. Program of School of Dentistry,…. Hauptthemen laut MEDLINE: Vascular Endothelial Growth Factor Receptor-2, Vascular Endothelial Growth Factor A, Carcinoma, Squamous Cell, Mouth Neoplasms. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nippon Foundation, Japan Society for the Promotion of Science, Osaka University.
Abstract (Originalsprache)
Oral squamous cell carcinoma (OSCC) is an aggressive malignancy with poor clinical outcomes driven by metastasis and recurrence. Vascular endothelial growth factor receptor 2 (VEGFR2), a key mediator of vascular endothelial growth factor A (VEGFA)-dependent angiogenesis, has recently been implicated in tumor cell-intrinsic signaling; however, its role in OSCC remains unclear. This study investigated VEGFA-VEGFR2 signaling in OSCC using a 4-nitroquinoline 1-oxide-induced mouse carcinogenesis model and human tissue specimens. Spatial transcriptomic analysis of murine tongues demonstrated enrichment of Kdr (Vegfr2) and Vegfa expression in tumor regions. Immunohistochemical analyses demonstrated up-regulation of VEGFR2, particularly nuclear VEGFR2, during tumor development. Exogenous VEGFA increased VEGFR2 expression and induced its nuclear localization in murine carcinoma cells. In human tongue squamous cell carcinoma, VEGFR2 was localized in the cytoplasm and nucleus, and nuclear VEGFR2 expression was significantly associated with tumor stage, lymph node metastasis, and proliferative activity. Nuclear VEGFR2 expression also correlated with VEGFA expression in epithelial and stromal compartments. Functional analyses showed that VEGFA-VEGFR2 signaling enhanced cell migration and stem-like properties independently of angiogenesis. These findings indicate that nuclear VEGFR2 reflects pathway activation and contributes to tumor aggressiveness, highlighting its potential as a biomarker and therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Pathology, University of Osaka Graduate School of Dentistry, Suita, Japan; Ph.D. Program of School of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan.
- Department of Oral and Maxillofacial Pathology, University of Osaka Graduate School of Dentistry, Suita, Japan.
- Department of Oral and Maxillofacial Pathology, University of Osaka Graduate School of Dentistry, Suita, Japan; Center for Infectious Disease Education and Research, University of Osaka, Suita, Japan. Electronic address…
- Department of Molecular and Cellular Biochemistry, University of Osaka Graduate School of Dentistry, Suita, Japan; Center of Excellence in Precision Medicine and Digital Health, Department of Physiology, Faculty of Dent…
- School of Oral Hygiene, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan; Research Center of Oral Translational Medicine, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan.
- School of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan; Division of Prosthodontics, Department of Oral Medicine, Taipei Medical University Hospital, Taipei, Taiwan.
Förderung
- Nippon Foundation
- Japan Society for the Promotion of Science
- Osaka University
Zitieren
APA
Li, L. J., Teramoto, A., Usami, Y., Hirose, K., Hata, K., Chang, W. M., Feng, S. W., & Toyosawa, S. (2026). The Vascular Endothelial Growth Factor A–Vascular Endothelial Growth Factor Receptor 2 Axis Drives Malignant Potential in Oral Squamous Cell Carcinoma by Promoting Stemness and Cell Proliferation. The American Journal of Pathology. https://doi.org/10.1016/j.ajpath.2026.07.011
Vancouver
Li LJ, Teramoto A, Usami Y, Hirose K, Hata K, Chang WM, et al. The Vascular Endothelial Growth Factor A–Vascular Endothelial Growth Factor Receptor 2 Axis Drives Malignant Potential in Oral Squamous Cell Carcinoma by Promoting Stemness and Cell Proliferation. The American Journal of Pathology. 2026. doi:10.1016/j.ajpath.2026.07.011
BibTeX
@article{Li2026,
author = {Li, Li-Jie and Teramoto, Akari and Usami, Yu and Hirose, Katsutoshi and Hata, Kenji and Chang, Wei-Min and Feng, Sheng-Wei and Toyosawa, Satoru},
title = {The Vascular Endothelial Growth Factor A–Vascular Endothelial Growth Factor Receptor 2 Axis Drives Malignant Potential in Oral Squamous Cell Carcinoma by Promoting Stemness and Cell Proliferation},
journal = {The American Journal of Pathology},
year = {2026},
doi = {10.1016/j.ajpath.2026.07.011}
}
EUVIMED